Northern Trust’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,619
| Closed | -$27.6K | – | 4431 |
|
|
2024
Q4 | $27.6K | Buy |
4,619
+2,072
| +81% | +$12.4K | ﹤0.01% | 4346 |
|
|
2024
Q3 | $24.9K | Sell |
2,547
-9,638
| -79% | -$94.1K | ﹤0.01% | 4317 |
|
|
2024
Q2 | $250K | Sell |
12,185
-1,040
| -8% | -$21.3K | ﹤0.01% | 3776 |
|
|
2024
Q1 | $597K | Sell |
13,225
-862
| -6% | -$38.9K | ﹤0.01% | 3507 |
|
|
2023
Q4 | $665K | Sell |
14,087
-17
| -0.1% | -$802 | ﹤0.01% | 3447 |
|
|
2023
Q3 | $571K | Sell |
14,104
-1,153
| -8% | -$46.7K | ﹤0.01% | 3478 |
|
|
2023
Q2 | $1.63M | Buy |
15,257
+2,028
| +15% | +$216K | ﹤0.01% | 3130 |
|
|
2023
Q1 | $3.95M | Sell |
13,229
-251
| -2% | -$74.9K | ﹤0.01% | 2598 |
|
|
2022
Q4 | $4.63M | Buy |
13,480
+488
| +4% | +$168K | ﹤0.01% | 2531 |
|
|
2022
Q3 | $2.46M | Buy |
12,992
+118
| +0.9% | +$22.3K | ﹤0.01% | 2904 |
|
|
2022
Q2 | $2.72M | Buy |
12,874
+711
| +6% | +$150K | ﹤0.01% | 2881 |
|
|
2022
Q1 | $4.07M | Buy |
12,163
+81
| +0.7% | +$27.1K | ﹤0.01% | 2707 |
|
|
2021
Q4 | $3.93M | Buy |
12,082
+201
| +2% | +$65.4K | ﹤0.01% | 2836 |
|
|
2021
Q3 | $5.77M | Buy |
11,881
+583
| +5% | +$283K | ﹤0.01% | 2634 |
|
|
2021
Q2 | $5.25M | Buy |
11,298
+923
| +9% | +$429K | ﹤0.01% | 2805 |
|
|
2021
Q1 | $7.17M | Sell |
10,375
-1,342
| -11% | -$927K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $8.66M | Sell |
11,717
-150
| -1% | -$111K | ﹤0.01% | 2338 |
|
|
2020
Q3 | $8.23M | Buy |
11,867
+1,025
| +9% | +$711K | ﹤0.01% | 2223 |
|
|
2020
Q2 | $9.2M | Buy |
10,842
+2,784
| +35% | +$2.36M | ﹤0.01% | 2147 |
|
|
2020
Q1 | $2.88M | Buy |
8,058
+664
| +9% | +$237K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $1.73M | Buy |
7,394
+421
| +6% | +$98.4K | ﹤0.01% | 3206 |
|
|
2019
Q3 | $786K | Buy |
6,973
+4,234
| +155% | +$477K | ﹤0.01% | 3452 |
|
|
2019
Q2 | $481K | Buy |
2,739
+1,951
| +248% | +$343K | ﹤0.01% | 3560 |
|
|
2019
Q1 | $125K | Buy |
+788
| New | +$125K | ﹤0.01% | 3873 |
|